Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals

BACKGROUND: Cancer predisposes patients to Clostridium difficile infection (CDI) due to health care exposures and medications that disrupt the gut microbiota or reduce immune response. Despite this association, the national rate of CDI among cancer patients is unknown. Furthermore, it is unclear how...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado, Andrew, Reveles, Ivan A., Cabello, Felicia T., Reveles, Kelly R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481960/
https://www.ncbi.nlm.nih.gov/pubmed/28645266
http://dx.doi.org/10.1186/s12879-017-2553-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481960/
https://www.ncbi.nlm.nih.gov/pubmed/28645266
http://dx.doi.org/10.1186/s12879-017-2553-z

Ejemplares similares